<DOC>
	<DOCNO>NCT01184443</DOCNO>
	<brief_summary>The purpose trial evaluate safety efficacy atypical antipsychotic , olanzapine , treatment youth suffer Anorexia Nervosa ( AN ) . Adolescent male female age 11 17 year treat physician Eating Disorder team Children 's Hospital Eastern Ontario invite join study diagnose AN Eating Disorder Not Otherwise Specified ( EDNOS ) , weigh less equal 85 % ideal body weight . Those meet inclusion exclusion criterion , consent participate trial offer adjunctive treatment olanzapine . Those agree take olanzapine belong olanzapine group , decline belong comparison group . Olanzapine dose keep investigator current clinical practice , flex dos range 1.25 mg 10.0 mg daily ( majority patient treat 2.5 mg 5.0 mg bedtime ) ; dose adjustment make base individual need tolerability . Participants remain study 12 week . Those initially decline olanzapine treatment may change mind take olanzapine week 9 trial . It hypothesize child adolescent choose take olanzapine entry trial motivate recover compliant treatment . Compared receive medication , expect adolescent demonstrate reduce disordered eating attitude behaviour , well increased rate weight gain . Finally , predict rate discontinuation adverse effect olanzapine minor give relatively low dose ( compare treatment patient schizophrenia ) , slow titration , short-term use olanzapine investigator use . By compare well-being outcome patient two group , investigator hope begin answer question whether olanzapine lead improve clinical outcome patient severe eat disorder AN EDNOS , question whether benefit use medication outweigh risk .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Olanzapine Anorexia Nervosa Children Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Male female 11 17 ( less 18 ) begin trial Based Diagnostic Statistical Manual Mental Disorders ( DSMIV ) , patient fulfills criterion diagnosis Anorexia Nervosa ( two type : restrict bingeeating/purging ) Eating Disorder Not Otherwise Specified , weight less equal 85 % ideal body weight , best determine time assessment Treated physician eat disorder team Children 's Hospital Eastern Ontario ( CHEO ) Currently receive treatment antipsychotic medication , mood stabiliser , stimulant Known diagnosis : diabetes , impair glucose tolerance , hyperlipidemia , hepatic dysfunction , substance dependence , narrow angle glaucoma , paralytic ileus , pancreatitis , medical illness would consider significantly impact treatment recovery eat disorder Any uncontrolled comorbid disease affect system include infectious , endocrine , renal , gastroenterologic , respiratory , cardiac , immunologic , hematologic . Potential participant control comorbidities area may invite participate discretion primary investigator . Experienced one seizures without clear resolve etiology Inability comply trial requirement include lack comprehension English Pregnant breastfeed High blood pressure Known allergy know sensitivity product olanzapine Other unspecified reason , opinion investigator , amke patient unsuitable enrollment Officially declare incapable consent treatment Mental Health Act ( Note : If patient involuntarily hospitalize , invited participate provide officially deem incapable make treatment decision Mental Health Act ) Clinically judge serious suicidal ri More 6 month pass patient 's initial eat disorder assessment time study entry Liver function test ( ALT ) &gt; 1.5 x upper limit normal ( ULN ) Positive pregnancy test Electrocardiogram ( ECG ) : QTc &gt; 450 msec arrythmia sinus bradycardia ; conduction abnormality , prolong QTc LDLC &gt; 4.9 mmol/L Total cholesterol/HDL ratio &gt; 6 Fasting glucose &gt; equal 6.1 mmol/L Neutrophil count &lt; 0.5 x 10^9/L Prolactin level assessment &gt; 200 ng/mL</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Anorexia Nervosa</keyword>
	<keyword>Eating Disorder Not Otherwise Specified</keyword>
	<keyword>Olanzapine</keyword>
	<keyword>Pediatric</keyword>
</DOC>